Less sleep means higher risk of diabetes and obesity

Less sleep, disrupted internal 24-hour clock means higher risk of diabetes and obesity – A new study reinforces the finding that too little sleep or sleep patterns that are inconsistent with our body’s “internal biological clock” may lead to increased risk of diabetes and obesity. This finding has been seen in short-term lab studies and when observing human subjects via epidemiological studies.

New drug tasimelteon for jet lag

Clinical trial results on the sleep-promoting effects of Vanda Pharmaceuticals’ circadian regulator tasimelteon (VEC-162) published in the Lancet. – Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) reports publication in The Lancet, one of the world’s leading medical journals, results of clinical trials of its novel circadian regulator, experimental compound tasimelteon (VEC-162).